Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum

vascular calcification

  • You have accessRestricted Access
    In Search of the Optimal Target for Phosphate Control: Episode 1
    Ron Wald and Michael W. Walsh
    JASN March 2021, 32 (3) 526-528; DOI: https://doi.org/10.1681/ASN.2021010027
    Add to Selected Citations
  • A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)
    You have accessRestricted Access
    A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)
    Nigel D. Toussaint, Eugenia Pedagogos, Nicole M. Lioufas, Grahame J. Elder, Elaine M. Pascoe, Sunil V. Badve, Andrea Valks, Geoffrey A. Block, Neil Boudville, James D. Cameron, Katrina L. Campbell, Sylvia S.M. Chen, Randall J. Faull, Stephen G. Holt, Dana Jackson, Meg J. Jardine, David W. Johnson, Peter G. Kerr, Kenneth K. Lau, Lai-Seong Hooi, Om Narayan, Vlado Perkovic, Kevan R. Polkinghorne, Carol A. Pollock, Donna Reidlinger, Laura Robison, Edward R. Smith, Robert J. Walker, Angela Yee Moon Wang, Carmel M. Hawley and IMPROVE-CKD Trial Investigators
    JASN November 2020, 31 (11) 2653-2666; DOI: https://doi.org/10.1681/ASN.2020040411
    Add to Selected Citations
  • Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial
    You have accessRestricted Access
    Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial
    Miles D. Witham, Jennifer S. Lees, Myra White, Margaret Band, Samira Bell, Donna J. Chantler, Ian Ford, Roberta L. Fulton, Gwen Kennedy, Roberta C. Littleford, Ian V. McCrea, Deborah McGlynn, Maurizio Panarelli, Maximilian R. Ralston, Elaine Rutherford, Alison Severn, Nicola Thomson, Jamie P. Traynor, Allan D. Struthers, Kirsty Wetherall and Patrick B. Mark
    JASN October 2020, 31 (10) 2434-2445; DOI: https://doi.org/10.1681/ASN.2020020225
    Add to Selected Citations
  • Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study
    You have accessRestricted Access
    Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study
    An S. De Vriese, Rogier Caluwé, Lotte Pyfferoen, Dirk De Bacquer, Koen De Boeck, Joost Delanote, Didier De Surgeloose, Piet Van Hoenacker, Bruno Van Vlem and Francis Verbeke
    JASN January 2020, 31 (1) 186-196; DOI: https://doi.org/10.1681/ASN.2019060579
    Add to Selected Citations
  • Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance
    You have accessRestricted Access
    Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance
    Britt Opdebeeck, Stuart Maudsley, Abdelkrim Azmi, Annelies De Maré, Wout De Leger, Bjorn Meijers, Anja Verhulst, Pieter Evenepoel, Patrick C. D’Haese and Ellen Neven
    JASN May 2019, 30 (5) 751-766; DOI: https://doi.org/10.1681/ASN.2018060609
    Add to Selected Citations
  • Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-<em>κ</em>B
    You have accessRestricted Access
    Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB
    Jakob Voelkl, Rashad Tuffaha, Trang T.D. Luong, Daniel Zickler, Jaber Masyout, Martina Feger, Nicolas Verheyen, Florian Blaschke, Makoto Kuro-o, Andreas Tomaschitz, Stefan Pilz, Andreas Pasch, Kai-Uwe Eckardt, Juergen E. Scherberich, Florian Lang, Burkert Pieske and Ioana Alesutan
    JASN June 2018, 29 (6) 1636-1648; DOI: https://doi.org/10.1681/ASN.2017050492
    Add to Selected Citations
  • You have accessRestricted Access
    K-alcification Protection in Dialysis Patients: The Underestimated Phenomenon of Vitamin K Deficiency
    Markus Ketteler and Vincent Matthias Brandenburg
    JASN June 2017, 28 (6) 1667-1668; DOI: https://doi.org/10.1681/ASN.2017020180
    Add to Selected Citations
  • You have accessRestricted Access
    Vitamin K–Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis
    Sagar U. Nigwekar, Donald B. Bloch, Rosalynn M. Nazarian, Cees Vermeer, Sarah L. Booth, Dihua Xu, Ravi I. Thadhani and Rajeev Malhotra
    JASN June 2017, 28 (6) 1717-1722; DOI: https://doi.org/10.1681/ASN.2016060651
    Add to Selected Citations
  • You have accessRestricted Access
    A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors
    Sagar U. Nigwekar, Sophia Zhao, Julia Wenger, Jeffrey L. Hymes, Franklin W. Maddux, Ravi I. Thadhani and Kevin E. Chan
    JASN November 2016, 27 (11) 3421-3429; DOI: https://doi.org/10.1681/ASN.2015091065
    Add to Selected Citations
  • You have accessRestricted Access
    Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis
    Ercan Ok, Gulay Asci, Selen Bayraktaroglu, Huseyin Toz, Mehmet Ozkahya, Mumtaz Yilmaz, Fatih Kircelli, Ebru Sevinc Ok, Naim Ceylan, Soner Duman, Mustafa Cirit, Marie-Claude Monier-Faugere and Hartmut H. Malluche
    JASN August 2016, 27 (8) 2475-2486; DOI: https://doi.org/10.1681/ASN.2015030268
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire